AstraZeneca (AZN) Short Interest Ratio & Short Volume $65.35 +0.91 (+1.41%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AstraZeneca Short Interest DataAstraZeneca (AZN) has a short interest of 7.40 million shares. This marks a -8.30% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.4, indicating that it would take 1.4 days of the average trading volume of 5.34 million shares to cover all short positions.Current Short Interest7,400,000 sharesPrevious Short Interest8,070,000 sharesChange Vs. Previous Month-8.30%Dollar Volume Sold Short$500.39 millionShort Interest Ratio1.4 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares3,100,634,000 sharesPercentage of Shares Shorted0.24%Today's Trading Volume9,077,313 sharesAverage Trading Volume5,342,888 sharesToday's Volume Vs. Average170% Short Selling AstraZeneca? Sign up to receive the latest short interest report for AstraZeneca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAZN Short Interest Over TimeAZN Days to Cover Over TimeAZN Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin AstraZeneca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20247,400,000 shares $500.39 million -8.3%N/A1.4 $67.62 11/15/20248,070,000 shares $510.27 million +74.3%N/A1.5 $63.23 10/31/20244,630,000 shares $329.42 million +14.9%N/A0.9 $71.15 10/15/20244,030,000 shares $313.74 million -25.2%N/A0.9 $77.85 9/30/20245,390,000 shares $419.93 million -16.4%N/A1.2 $77.91 9/15/20246,450,000 shares $504.84 million -27.2%N/A1.5 $78.27 Get the Latest News and Ratings for AZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 8/31/20248,860,000 shares $776.31 million +4.1%N/A2.1 $87.62 8/15/20248,510,000 shares $722.50 million +49.0%N/A2.1 $84.90 7/31/20245,710,000 shares $451.95 million -1.6%N/A1.4 $79.15 7/15/20245,800,000 shares $453.10 million -9.5%N/A1.4 $78.12 6/30/20246,410,000 shares $499.92 million -19.2%N/A1.4 $77.99 6/15/20247,930,000 shares $631.15 million +18.9%N/A1.6 $79.59 5/31/20246,670,000 shares $520.39 million -13.0%N/A1.3 $78.02 5/15/20247,670,000 shares $590.36 million -10.1%N/A1.4 $76.97 4/30/20248,530,000 shares $647.26 million -0.6%N/A1.3 $75.88 4/15/20248,580,000 shares $589.70 million +12.0%N/A1.4 $68.73 3/31/20247,660,000 shares $518.97 million -26.9%N/A1.2 $67.75 3/15/202410,480,000 shares $694.93 million +13.2%N/A1.7 $66.31 2/29/20249,260,000 shares $594.12 million +3.8%N/A1.5 $64.16 2/15/20248,920,000 shares $560.53 million +117.6%N/A1.4 $62.84 1/31/20244,100,000 shares $273.22 million -29.4%N/A0.7 $66.64 1/15/20245,810,000 shares $403.33 million -6.6%N/A1.1 $69.42 12/31/20236,220,000 shares $418.92 million +8.9%N/A1.1 $67.35 12/15/20235,710,000 shares $370.01 million -27.7%N/A1 $64.80 11/30/20237,900,000 shares $510.26 million -2.5%N/A1.4 $64.59 11/15/20238,100,000 shares $511.35 million -10.1%N/A1.6 $63.13 10/31/20239,010,000 shares $569.70 million +53.8%N/A1.8 $63.23 10/15/20235,860,000 shares $394.55 million -3.9%N/A1.2 $67.33 9/30/20236,100,000 shares $413.09 million -27.2%N/A1.3 $67.72 9/15/20238,380,000 shares $572.10 million +14.3%N/A1.6 $68.27 8/31/20237,330,000 shares $497.12 million +49.0%N/A1.4 $67.82 8/15/20234,920,000 shares $341.99 million -18.7%N/A0.9 $69.51 7/31/20236,050,000 shares $433.79 million -5.2%N/A1.2 $71.70 7/15/20236,380,000 shares $429.88 million -15.9%N/A1.3 $67.38 6/30/20237,590,000 shares $543.22 million +27.1%N/A1.7 $71.57 6/15/20235,970,000 shares $445.48 million +22.3%N/A1.4 $74.62 5/31/20234,880,000 shares $356.63 million +4.5%N/A1.2 $73.08 5/15/20234,670,000 shares $350.20 million -19.6%N/A1.2 $74.99 4/30/20235,810,000 shares $425.41 million +44.5%N/A1.3 $73.22 4/15/20234,020,000 shares $296.92 million +6.1%N/A0.8 $73.86Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/20233,790,000 shares $263.06 million +21.5%N/A0.8 $69.41 3/15/20233,120,000 shares $201.49 million -10.1%N/A0.6 $64.58 2/28/20233,470,000 shares $226.17 million +28.5%N/A0.7 $65.18 2/15/20232,700,000 shares $188.16 million +8.0%N/A0.6 $69.69 1/31/20232,500,000 shares $163.43 million -50.3%N/A0.5 $65.37 1/15/20235,030,000 shares $357.53 million +18.9%N/A1 $71.08 12/30/20224,230,000 shares $286.79 million -14.2%N/A0.8 $67.80 12/15/20224,930,000 shares $343.82 million +13.3%N/A0.9 $69.74 11/30/20224,350,000 shares $295.67 million -6.7%N/A0.7 $67.97 11/15/20224,660,000 shares $298.01 million -14.3%N/A0.7 $63.95 10/31/20225,440,000 shares $319.93 million -5.6%N/A0.8 $58.81 10/15/20225,760,000 shares $316.63 million +20.8%N/A0.9 $54.97 9/30/20224,770,000 shares $261.59 million -25.7%N/A0.7 $54.84 9/15/20226,420,000 shares $373.26 million -29.4%N/A1 $58.14 8/31/20229,090,000 shares $567.03 million -12.5%N/A1.4 $62.38 8/15/202210,390,000 shares $694.16 million -23.8%N/A1.7 $66.81 7/31/202213,640,000 shares $903.38 million -0.2%N/A2.1 $66.23 7/15/202213,670,000 shares $920.81 million +4.2%N/A2 $67.36 6/30/202213,120,000 shares $866.84 million -11.1%N/A1.9 $66.07 6/15/202214,760,000 shares $894.01 million +36.2%N/A2.1 $60.57 5/31/202210,840,000 shares $720.64 million -34.0%N/A1.6 $66.48 5/15/202216,420,000 shares $1.04 billion +39.7%N/A2.1 $63.14 4/30/202211,750,000 shares $780.20 million +8.6%N/A1.5 $66.40 4/15/202210,820,000 shares $747.12 million +39.4%N/A1.3 $69.05 3/31/20227,760,000 shares $514.80 million -1.7%N/A1 $66.34 3/15/20227,890,000 shares $484.21 million -12.6%N/A1.1 $61.37 2/28/20229,030,000 shares $549.75 million +9.7%N/A1.3 $60.88 2/15/20228,230,000 shares $496.27 million +54.7%N/A1.3 $60.30 1/31/20225,320,000 shares $309.68 million -12.8%N/A1 $58.21 1/15/20226,100,000 shares $358.99 million -1.3%N/A1.3 $58.85 12/31/20216,180,000 shares $359.99 million -1.6%N/A1.4 $58.25 12/15/20216,280,000 shares $349.92 million -16.8%N/A1.3 $55.72 11/30/20217,550,000 shares $413.97 million +8.5%N/A1.4 $54.83 11/15/20216,960,000 shares $416.07 million +2.7%N/A1.3 $59.78 10/29/20216,780,000 shares $422.94 million -5.0%N/A1.3 $62.38 10/15/20217,140,000 shares $429.97 million -0.1%N/A1.2 $60.22 9/30/20217,150,000 shares $429.43 million +9.5%N/A0.7 $60.06 9/15/20216,530,000 shares $368.62 million +1.9%N/A0.7 $56.45 8/31/20216,410,000 shares $373.57 million +14.3%N/A0.6 $58.28 8/13/20215,610,000 shares $328.07 million -25.5%N/A0.5 $58.48 7/30/20217,530,000 shares $431.02 million -94.7%N/A0.7 $57.24 7/15/2021142,900,000 shares $8.14 billion +4.4%N/A14 $56.96 6/30/2021136,940,000 shares $8.20 billion +1.4%5.2%17.4 $59.90 6/15/2021135,110,000 shares $7.95 billion +2.3%5.2%17 $58.84 5/28/2021132,060,000 shares $7.50 billion +5.3%5.0%15.5 $56.77 5/14/2021125,410,000 shares $6.90 billion +6.2%N/A12.8 $55.05 4/30/2021118,090,000 shares $6.07 billion +10.1%N/A11.6 $51.37 4/15/2021107,270,000 shares $5.35 billion +8.8%N/A10 $49.84 3/31/202198,560,000 shares $4.93 billion +3.8%N/A9.2 $49.97 3/15/202194,940,000 shares $4.60 billion +10.0%N/A8 $48.42Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/26/202186,280,000 shares $4.22 billion +10.8%N/A6.9 $48.91 2/12/202177,900,000 shares $3.90 billion +18.2%N/A6.4 $50.09 1/29/202165,920,000 shares $3.43 billion +32.0%N/A5.9 $52.04 1/15/202149,930,000 shares $2.56 billion +49.1%N/A4.7 $51.29 11/30/20204,360,000 shares $229.38 million -30.7%N/A0.8 $52.61 11/15/20206,290,000 shares $360.92 million +4.0%N/A1.3 $57.38 10/30/20206,050,000 shares $308.97 million +20.3%N/A1.4 $51.07 10/15/20205,030,000 shares $267.55 million -1.4%N/A1.2 $53.19 9/30/20205,100,000 shares $279.48 million +18.3%N/A0.8 $54.80 9/15/20204,310,000 shares $238.26 million +4.4%N/A0.7 $55.28 8/31/20204,130,000 shares $231.28 million -37.2%N/A0.6 $56.00 8/14/20206,580,000 shares $363.15 million -4.1%N/A1 $55.19 7/31/20206,860,000 shares $382.65 million +453.2%N/A1 $55.78 7/15/20201,240,000 shares $66.94 million -35.4%N/A0.2 $53.98 6/30/20201,920,000 shares $101.59 million -33.1%N/A0.4 $52.91 6/15/20202,870,000 shares $151.08 million -9.5%N/A0.6 $52.64 5/29/20203,170,000 shares $173.08 million -11.0%N/A0.6 $54.60 5/15/20203,560,000 shares $190.14 million -1.4%N/A0.7 $53.41 4/30/20203,610,000 shares $188.73 million -12.2%N/A0.8 $52.28 4/15/20204,110,000 shares $197.40 million -10.9%N/A0.9 $48.03 3/31/20204,610,000 shares $205.88 million -35.7%N/A1 $44.66 3/13/20207,174,500 shares $303.34 million -20.0%0.3%2.3 $42.28 2/28/20208,970,000 shares $347.86 million +14.4%N/A2.9 $38.78 2/14/20207,840,000 shares $367.70 million +15.0%N/A2.7 $46.90 1/31/20206,820,000 shares $324.43 million +69.2%N/A2.6 $47.57 1/15/20204,030,000 shares $200.61 million -11.6%N/A1.4 $49.78 12/31/20194,560,000 shares $224.72 million -8.3%N/A1.7 $49.28 AZN Short Interest - Frequently Asked Questions What is AstraZeneca's current short interest? Short interest is the volume of AstraZeneca shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 7,400,000 shares of AZN short. Learn More on AstraZeneca's current short interest. What is a good short interest ratio for AstraZeneca? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZN shares currently have a short interest ratio of 1.0. Learn More on AstraZeneca's short interest ratio. Which institutional investors are shorting AstraZeneca? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AstraZeneca: Barclays PLC, Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Walleye Trading LLC, Walleye Capital LLC, Citigroup Inc., LMR Partners LLP, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is AstraZeneca's short interest increasing or decreasing? AstraZeneca saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 7,400,000 shares, a decrease of 8.3% from the previous total of 8,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AstraZeneca's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AstraZeneca: Novo Nordisk A/S (0.13%), Novartis AG (0.23%), Sanofi (0.18%), GSK plc (0.95%), Takeda Pharmaceutical Company Limited (0.15%), BioNTech SE (0.99%), Teva Pharmaceutical Industries Limited (1.98%), BeiGene, Ltd. (1.36%), Moderna, Inc. (11.90%), Viatris Inc. (1.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short AstraZeneca stock? Short selling AZN is an investing strategy that aims to generate trading profit from AstraZeneca as its price is falling. AZN shares are trading up $0.91 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AstraZeneca? A short squeeze for AstraZeneca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AZN, which in turn drives the price of the stock up even further. How often is AstraZeneca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZN, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies NVO Short Squeeze NVS Short Squeeze SNY Short Squeeze GSK Short Squeeze TAK Short Squeeze BNTX Short Squeeze TEVA Short Squeeze BGNE Short Squeeze MRNA Short Squeeze VTRS Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AZN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZN Stock Alerts